Detalhe da pesquisa
1.
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
BMJ Open
; 14(3): e081348, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531587
2.
Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries.
Expert Opin Drug Saf
; 21(3): 435-446, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806928